Tweenvest Stocks

SOHM, Inc. (OTCPK: SHMN)

Health Care · Pharmaceuticals · US

$0.00

+5.26% today · -33.3% 1Y

SOHM, Inc. (OTCPK: SHMN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.61M and employs 11 people.

Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.00.

Tweenvest scores SOHM, Inc. across four factors: quality 18/100, value 51/100. Its strongest factor is value.

SHMN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$2.61M
Revenue (TTM)
$1.30M
P/E
EPS
-0.00
Dividend yield
Beta (5Y)
0.78
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
Shares outstanding
2.90B
Employees
11
Next earnings

About SOHM, Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.

ISIN
US83408P1084
Founded
2005
Listed since
Mar 31, 2010
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,257.35+0.16%
Johnson & JohnsonNYSE: JNJ$651.25B$271.37+0.42%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF370.40-1.38%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£121.48-0.76%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.15+0.29%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.